A report says Martin Shkreli's Turing Pharmaceuticals will 'roll back' the price of a lifesaving treatment for people living with HIV — but only for hospitals.
The pharmaceutical CEO, who recently hiked the cost of an AIDS drug, had hoped to parlay his contribution into a private meeting with the presidential candidate.
